HDT Bio Corp.

Private

Seattle, WashingtonHealthcare & Life Scienceshttps://hdt.bio/

Last Round

Grant

Sep 17, 2024

Total Funding Raised

$73.25M

Company Overview

HDT Bio Corp. is a biotechnology company developing drugs and vaccines for the immunotherapy of cancers and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

lipid nanoparticleLNPRNA deliveryvaccine developmentimmunotherapydrug delivery platformbiotechnologymRNA vaccinemedical countermeasuresoncology therapeuticstechnology licensingclinical-stage biotechB2Gbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HDT Bio Corp. Comparables

Compare HDT Bio Corp. with similar companies based on industry and business-model similarity.

HDT Bio Corp. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Entos Pharmaceuticals	85%
Genevant Sciences	83%
Acuitas Therapeutics	83%

View all Comparables

HDT Bio Corp. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Sep 17, 2024
Grant	Jan 23, 2024
Grant	Oct 4, 2023
Grant	Nov 30, 2022
Grant	Aug 8, 2022
Grant	Jul 20, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Steven Reed

Co-Founder CEO

Founding Team

HDT Bio Corp. Investors

Notable investors and investment history

HDT Bio Corp. investors
Investor	Rounds
National Institute of Allergy and Infectious Diseases	Grant
U.S. Department of Health and Human Services	Grant
U.S. Department of Defense	Grant
Public Health Emergency Medical Countermeasures Enterprise	Grant
U.S. Army Medical Research Acquisition Activity	Grant
U.S. Department of War	Grant
Johnson & Johnson Innovation - JJDC, Inc.	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 20, 2025
Developing a vaccine platform in collaboration with RML, currently in animal model evaluations.
Jan 23, 2024
$749K grant received from BARDA and PHEMCE.

View all signals

HDT Bio Corp. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

HDT Bio Corp. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HDT Bio Corp.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington

Employee Range54

Year Founded2018

Last FundingSep 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.